References
- Aggarwal S, Gupta S, Gupta MK, et al (2011). Possible role of epidermal growth factor receptors in the therapy of pancreatic cancer. Crit Rev Ther Drug Carrier Syst, 28, 293-356. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v28.i4.10
- Azizi A, Naguib NN, Mbalisike E, et al (2011). Liver metastases of pancreatic cancer: role of repetitive transarterial chemoembolization (TACE) on tumor response and survival. Pancreas, 40, 1271-5. https://doi.org/10.1097/MPA.0b013e318220e5b9
- Dong QZ, Zhao Y, Liu Y, et al (2010). Overexpression of SCC-S2 correlates with lymph node metastasis and poor prognosis in patients with non-small-cell lung. Cancer Sci, 101, 1562-9. https://doi.org/10.1111/j.1349-7006.2010.01557.x
- Freundt EC, Bidere N, Lenardo MJ (2008). A different TIPE of immune homeostasis. Cell, 133, 401-2. https://doi.org/10.1016/j.cell.2008.04.017
- Hong SM, Park JY, Hruban RH, et al (2011). Molecular signatures of pancreatic cancer. Arch Pathol Lab Med, 135, 716-27.
- Ioannou N, Dalgleish AG, Seddon AM, et al (2011). Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells. Br J Cancer, 105, 1554-62. https://doi.org/10.1038/bjc.2011.396
- Kumar D, Whiteside TL, Kasid U (2000). Identification of a novel tumor necrosis factor-alpha-inducible gene, SCC-S2, containing the consensus sequence of a death effector domain of fas-associated death domain-like interleukin- 1beta-converting enzyme-inhibitory protein. J Biol Chem, 275, 2973-8. https://doi.org/10.1074/jbc.275.4.2973
- Kumar D, Gokhale P, Broustas C et al (2004). Expression of SCC-S2, a antiapoptotic molecule, correlates with enhanced proliferation antumorigenicity of MDA-MB 435 cells. Oncogene, 23, 612-6. https://doi.org/10.1038/sj.onc.1207123
- Patel S, Wang FH, Whiteside TL, et al(1997). Identification of seven differentially displayed transcripts in human primary and matched metastatic head and neck squamous cell carcinoma cell lines: implications in metastasis and/or radiation response. Oral Oncol, 33, 197-203. https://doi.org/10.1016/S0964-1955(96)00065-6
- Romanuik TL, Ueda T, Le N, et al (2009). Novel biomarkers for prostate cancer including noncoding transcripts. Am J Pathol, 175, 2264-76. https://doi.org/10.2353/ajpath.2009.080868
- Sharma C, Eltawil KM, Renfrew PD, et al (2011). Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. World J Gastroenterol, 17, 867-97. https://doi.org/10.3748/wjg.v17.i7.867
- Sun H, Gong S, Carmody RJ, et al (2008). TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell, 133, 415-26. https://doi.org/10.1016/j.cell.2008.03.026
- Vincent A, Herman J, Schulick R, et al (2011). Pancreatic cancer. Lancet, 378, 607-20. https://doi.org/10.1016/S0140-6736(10)62307-0
- Xu S, Weihua Z (2011). Loss of EGFR induced autophagy sensitizes hormone refractory prostate cancer cells to adriamycin. Prostate, 71, 1216-24. https://doi.org/10.1002/pros.21337
- You Z, Ouyang H, Lopatin D, et al (2001). Nuclear factorkappa B-inducible death effector domain-containing protein suppresses tumor necrosis factor-mediated apoptosis by inhibiting caspase-8 activity. J Biol Chem, 276, 26398-404. https://doi.org/10.1074/jbc.M102464200
- Zhang C, Chakravarty D, Sakabe I, et al (2006). Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression. Mol Ther, 13, 947-55. https://doi.org/10.1016/j.ymthe.2005.11.020
Cited by
- Prognostic Significance of Annexin A1 Expression in Pancreatic Ductal Adenocarcinoma vol.13, pp.9, 2012, https://doi.org/10.7314/APJCP.2012.13.9.4707
- Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents vol.35, pp.2, 2013, https://doi.org/10.1007/s00281-012-0340-x
- Variance of TNFAIP8 expression between tumor tissues and tumor-infiltrating CD4+ and CD8+ T cells in non-small cell lung cancer vol.35, pp.3, 2014, https://doi.org/10.1007/s13277-013-1307-9
- Correlation of TNFAIP8 overexpression with the proliferation, metastasis, and disease-free survival in endometrial cancer vol.35, pp.6, 2014, https://doi.org/10.1007/s13277-014-1770-y
- TNFAIP8 overexpression is associated with lymph node metastasis and poor prognosis in intestinal-type gastric adenocarcinoma vol.65, pp.4, 2014, https://doi.org/10.1111/his.12413
- Expression of tumor necrosis factor α-induced protein 8 is upregulated in human gastric cancer and regulates cell proliferation, invasion and migration vol.12, pp.2, 2015, https://doi.org/10.3892/mmr.2015.3690
- Inflammation and Cancer Development in Pancreatic and Biliary Tract Cancer vol.66, pp.6, 2015, https://doi.org/10.4166/kjg.2015.66.6.325
- Association between the expression levels of tumor necrosis factor-α-induced protein 8 and the prognosis of patients with gastric adenocarcinoma vol.12, pp.1, 2016, https://doi.org/10.3892/etm.2016.3327
- Regulation of inflammation and tumorigenesis by the TIPE family of phospholipid transfer proteins vol.14, pp.6, 2017, https://doi.org/10.1038/cmi.2017.4
- MicroRNA-9 inhibits the gastric cancer cell proliferation by targeting TNFAIP8 vol.50, pp.2, 2017, https://doi.org/10.1111/cpr.12331
- TNFAIP8 as a predictor of metastasis and a novel prognostic biomarker in patients with epithelial ovarian cancer vol.109, pp.6, 2013, https://doi.org/10.1038/bjc.2013.501
- TIPE Family of Proteins and Its Implications in Different Chronic Diseases vol.19, pp.10, 2018, https://doi.org/10.3390/ijms19102974